Press Releases
- Sep 14, 2016- Presentation with Live Webcast on Wednesday, September 21 at 11:30 a.m. PT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Aug 24, 2016- Presentation with Live Webcast on Monday, September 12 at 3:00 p.m. EDT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Aug 22, 2016- Recipient of NI Engineering Impact Award for Advanced Research in Regenerating and Restoring Organ Function Damaged by Disease or Trauma -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Aug 11, 2016- Q2 marked by positive, confirmatory proof-of-concept results in large-animal studies of proprietary Cellspan™ technology and manuscript with Mayo Clinic being finalized for publication
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Jul 28, 2016
Biostage, Inc. (NASDAQ: BSTG) a biotechnology company developing bioengineered organ implants for life-threatening conditions of the esophagus, trachea and bronchus, will host a conference call on...
